University of Gothenburg
  2. About
  3. Find staff
  4. Roger Olofsson Bagge

Roger Olofsson Bagge

Professor/ Chief Physician

Department of Surgery
Mail
roger.olofsson.bagge@gu.se
Visiting address
Blå stråket 5, vån 3 SU/Sahlgrenska
41345 Göteborg
Postal address
Sahlgrenska Universitetssjukhuset
41345 Göteborg

About Roger Olofsson Bagge

Gothenburg University's film about Roger's research in connection with his installation as a professor at the department of clinical sciences (1:30)

Roger Olofsson Bagge is Professor of Cancer Surgery at the University of Gothenburg and Senior Consultant Surgeon at Sahlgrenska University Hospital. He is based at the Institute of Clinical Sciences and leads an internationally recognised translational research group focusing on melanoma and breast cancer. His research spans advanced surgical oncology, regional cancer therapies, immunology, extracellular vesicles, and large-scale clinical registry studies.

He is a board member of Sahlgrenska Comprehensive Cancer Center (SCCC), affiliated with the Wallenberg Centre for Molecular and Translational Medicine (WCMTM), and from 2026 serves as Vice Head of Research at the Institute of Clinical Sciences. Roger Olofsson Bagge plays a leading role in the development and national organisation of highly specialised care in regional perfusion therapies in Sweden.

His scientific output includes more than 200 peer-reviewed publications, with an h-index of 27 (Web of Science). He has published in leading international journals such as The New England Journal of Medicine, Lancet Oncology, Nature Communications, JAMA Dermatology, British Journal of Surgery and Annals of Surgical Oncology. His work has had particular impact in isolated limb and hepatic perfusion, surgery in the era of modern immunotherapy, and individualised treatment strategies for melanoma and breast cancer.

Roger Olofsson Bagge is principal investigator of several national and international randomised clinical trials. These include the SCANDIUM I–III trials evaluating isolated hepatic perfusion for metastatic uveal melanoma, and the NivoILP trial combining immunotherapy with regional perfusion for melanoma in-transit metastases. In breast cancer research, he has played a central role in large multicentre studies such as SENOMAC, SentiNot and PhysSURG-B.

His research is extensively funded by major national and international funding bodies, including the Swedish Research Council, the Swedish Cancer Society, the Knut and Alice Wallenberg Foundation, the Sjöberg Foundation, and the American Association for Cancer Research. This funding supports both clinical trials and advanced preclinical research, including patient-derived xenograft (PDX) models, immunological profiling, and molecular characterisation of tumours.

As a supervisor and mentor, he is main or co-supervisor for a large number of PhD students and postdoctoral researchers, and has supervised multiple completed doctoral theses in surgery, oncology and translational cancer research. He also leads a biobank of patient-derived tumour models and coordinates broad national and international research collaborations.

Roger Olofsson Bagge is actively involved in several international expert and guideline groups, including EORTC, ESMO and the International Neoadjuvant Melanoma Consortium. He serves as Associate Editor of Annals of Surgical Oncology, is a member of the Editorial Board of British Journal of Surgery, and has received several prestigious awards, including the Swedish Surgical Society’s Major Research Award and the AACR Ocular Melanoma Foundation Career Development Award.

Link to Rogers Olofsson Bagges research group

ORCID: https://orcid.org/0000-0001-5795-0355

Pressrelease (2023-03-21) Effective treatment in rare but deadly form of cancer

Major research funding:

  • Swedish Research Council
  • Swedish Cancer Society
  • The Sjöberg Foundation
  • American Association for Cancer Research (AACR)
  • Wallenberg Foundation
  • Region Västra Götaland
  • Assar Gabrielsson foundation
  • Gothenburg Medical Association
  • Swedish state (ALF-agreement)
  • Gothenburg research council

Received prizes: